Harrell Investment Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,296
| Closed | -$1.25M | – | 133 |
|
|
2025
Q1 | $1.25M | Buy |
17,296
+5,811
| +51% | +$421K | 0.37% | 56 |
|
|
2024
Q4 | $850K | Sell |
11,485
-12,378
| -52% | -$916K | 0.24% | 67 |
|
|
2024
Q3 | $1.57M | Sell |
23,863
-877
| -4% | -$57.9K | 0.45% | 61 |
|
|
2024
Q2 | $2.29M | Sell |
24,740
-83
| -0.3% | -$7.67K | 0.66% | 50 |
|
|
2024
Q1 | $2.37M | Buy |
24,823
+699
| +3% | +$66.8K | 0.7% | 48 |
|
|
2023
Q4 | $1.84M | Sell |
24,124
-4,008
| -14% | -$306K | 0.57% | 52 |
|
|
2023
Q3 | $1.95M | Buy |
28,132
+1,747
| +7% | +$121K | 0.66% | 48 |
|
|
2023
Q2 | $2.49M | Sell |
26,385
-670
| -2% | -$63.2K | 0.84% | 43 |
|
|
2023
Q1 | $2.23M | Buy |
27,055
+2,524
| +10% | +$208K | 0.79% | 47 |
|
|
2022
Q4 | $1.83M | Sell |
24,531
-4,717
| -16% | -$352K | 0.72% | 46 |
|
|
2022
Q3 | $2.42M | Buy |
29,248
+1,972
| +7% | +$163K | 1.01% | 34 |
|
|
2022
Q2 | $2.59M | Buy |
27,276
+797
| +3% | +$75.8K | 1.06% | 35 |
|
|
2022
Q1 | $3.12M | Buy |
26,479
+2,101
| +9% | +$247K | 1.1% | 31 |
|
|
2021
Q4 | $3.16M | Buy |
24,378
+2,438
| +11% | +$316K | 0.97% | 35 |
|
|
2021
Q3 | $2.48M | Buy |
21,940
+5,133
| +31% | +$581K | 0.8% | 45 |
|
|
2021
Q2 | $1.74M | Buy |
16,807
+2,185
| +15% | +$226K | 0.56% | 55 |
|
|
2021
Q1 | $1.22M | Sell |
14,622
-1,072
| -7% | -$89.7K | 0.43% | 62 |
|
|
2020
Q4 | $1.43M | Sell |
15,694
-1,071
| -6% | -$97.7K | 0.55% | 57 |
|
|
2020
Q3 | $1.34M | Buy |
+16,765
| New | +$1.34M | 0.58% | 54 |
|